Skip to content

Clinical trials

Mood Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20053
20062
20071
20082
20191
20212
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayside Health2
Eli Lilly and Company2
Melbourne Health2
Praxis Precision Medicines2
Takeda2
The University of New South Wales2
H. Lundbeck A/S1
NORCE Norwegian Research Centre AS1
atai Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders15
Major Depressive Disorder11
Depressive Disorder8
Mental Disorders5
Dysthymic Disorder2
Psychotic Disorders2
Anxiety Disorders1
Attention Deficit and Disruptive Behavior Disorders1
Depressive Disorder, Treatment-Resistant1
Personality Disorders1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.